| In vivo genome editing improves motor function and extends survival in a mouse model of ALS T Gaj, DS Ojala, FK Ekman, LC Byrne, P Limsirichai, DV Schaffer Science advances 3 (12), eaar3952, 2017 | 197 | 2017 |
| CRISPR-mediated activation of latent HIV-1 expression P Limsirichai, T Gaj, DV Schaffer Molecular Therapy 24 (3), 499-507, 2016 | 140 | 2016 |
| Orthogonal control of expression mean and variance by epigenetic features at different genomic loci SS Dey, JE Foley, P Limsirichai, DV Schaffer, AP Arkin Molecular systems biology 11 (5), 806, 2015 | 119 | 2015 |
| Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery T Gaj, BT Staahl, GMC Rodrigues, P Limsirichai, FK Ekman, JA Doudna, ... Nucleic acids research 45 (11), e98-e98, 2017 | 97 | 2017 |
| Aag DNA glycosylase promotes alkylation-induced tissue damage mediated by Parp1 JA Calvo, CA Moroski-Erkul, A Lake, LW Eichinger, D Shah, I Jhun, ... PLoS genetics 9 (4), e1003413, 2013 | 71 | 2013 |
| Characterization of γ-Butyrolactone Autoregulatory Signaling Gene Homologs in the Angucyclinone Polyketide WS5995B Producer Streptomyces acidiscabies FG Healy, KP Eaton, P Limsirichai, JF Aldrich, AK Plowman, RR King Journal of bacteriology 191 (15), 4786-4797, 2009 | 38 | 2009 |
| Genome-wide activation screens to increase adeno-associated virus production CR Barnes, H Lee, DS Ojala, KK Lewis, P Limsirichai, DV Schaffer Molecular Therapy-Nucleic Acids 26, 94-103, 2021 | 26 | 2021 |
| In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci Adv. 2017; 3: eaar3952 T Gaj, DS Ojala, FK Ekman, LC Byrne, P Limsirichai, DV Schaffer | 9 | |
| In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci Adv. 2017; 3 (12): eaar3952 T Gaj, DS Ojala, FK Ekman, LC Byrne, P Limsirichai, DV Schaffer | 3 | |
| High-Throughput CRISPR/Cas9 Genome-Wide Screens to Enhance AAV Manufacturing C Barnes, D Ojala, P Limsirichai, D Schaffer MOLECULAR THERAPY 27 (4), 332-333, 2019 | | 2019 |
| Using CRISPR-Cas9 to Purge the Latent HIV Reservoir T Gaj, P Limsirichai, DV Schaffer MOLECULAR THERAPY 25 (5), 306-306, 2017 | | 2017 |
| In Vivo Genome Editing in the G93A-SOD1 Mouse Model of ALS Delays Disease Onset, Improves Motor Function and Extends Survival T Gaj, DS Ojala, FK Ekman, LC Byrne, P Limsirichai, DV Schaffer MOLECULAR THERAPY 25 (5), 108-108, 2017 | | 2017 |
| 125. Purging Latent HIV Infection by CRISPR-Mediated Viral Reactivation P Limsirichai, T Gaj, DV Schaffer Molecular Therapy 24, S52, 2016 | | 2016 |
| Reactivating Latent HIV-1 P Limsirichai University of California, Berkeley, 2016 | | 2016 |
David SchafferProfessor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience, UC BerkeleyEmail yang diverifikasi di berkeley.edu